ASU scientists’ success in regenerative medicine

Director of the Institute Ivan Smirnov said a couple words about the work on the new drug, which activates the process of stem cells production in the organism, renews the tissues and maintains the state of biologically young body. May be this medical product is a step towards creation of the remedy for aging.

“We are developing medical substances for curing such diseases as anemia, degenerative toxic induced liver and kidneys injury, radiation and chemotherapeutic impact on oncologic patients,” says Ivan Smirnov.

According to I. Smirnov, regenerative medicine product stimulates the process of stem cells generation that helps turn back the tide of degeneration of human organs. The main organ, which is used for drug trial, is liver.

“Our model organ is liver, because its transplantation is a very expensive process, and liver is an organ that needs regeneration, as it receives the most number of toxicants,” explained the scientists.

On the present stage the scientists are testing the anti-aging properties of the drug on such protozoa as worms, because it is easier to track the changes caused by the medicine in laboratory conditions due to their short longevity. In case of more complex experiments, for example, testing the medicine on laboratory mice, the results will be awaited for about 5 years.

“If our experiments prove the slowdown of aging through degeneration prevention in such simple organisms as worms, we will be able to measure the results of laboratory tests on human beings not earlier than in 50 years,” concluded the scientist.